Physician

Bassam Moushmoush, MD

According to 2025 Medicare claims, Bassam Moushmoush, MD (NPI: 1619961232) practices cardiology in the Charleston, WV market, with the plurality of this provider's patient population coming from Kanawha, WV. This provider's primary affiliated billing organization is CARDIOVASCULAR CONSULTANTS PLLC (NPI: 1588658199; TIN: 550766617) and primary practice location at 25301-1605. Moushmoush is affiliated with the ACO West Virginia (ACO ID: A3563) and Vandalia Health Network (ACO ID: A4513), participating under the MSSP model.

Moushmoush's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,454 traditional Medicare patients, billed 5,941 HCPCS/CPT codes, and received $357,760 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 6,681 prescription claims across 770 beneficiaries totaling $1,259,244 in drug costs, led by Eliquis (Apixaban). 2022 DME data shows 15 claims. Open Payments data shows 52 records totaling $1,399. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $695,688 to $357,760. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $331,341 to $1,259,244. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $13,364 and ending at $30,472.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,754	12,386	$695,688
2016	2,863	11,929	$654,135
2017	2,214	10,111	$584,246
2018	2,431	11,389	$693,620
2019	2,885	11,883	$704,639
2020	1,707	9,301	$592,939
2021	1,674	8,547	$552,123
2022	1,440	7,355	$496,431
2023	1,371	6,269	$387,967
2024	1,454	5,941	$357,760

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	595	7,249	$331,341
2016	714	8,051	$487,966
2017	764	8,307	$551,400
2018	916	8,992	$784,449
2019	923	8,254	$1,006,291
2020	923	7,711	$985,642
2021	972	8,579	$1,203,312
2022	935	8,498	$1,372,815
2023	883	7,746	$1,436,939
2024	770	6,681	$1,259,244

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	11	$22,529
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	15	$30,390
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	438	463	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	398	629	$84
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	320	438	$12
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	209	230	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	830	1,116	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	344	20,826	$400,646
Entresto	Sacubitril/Valsartan	173	10,505	$223,826
Jardiance	Empagliflozin	113	7,711	$143,069
Repatha Sureclick	Evolocumab	138	5,226	$100,380
Xarelto	Rivaroxaban	70	5,280	$96,413

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	52	$1,399	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bassam Moushmoush, MD?

Tedicare shows public-source Medicare data for Bassam Moushmoush, MD (NPI 1619961232), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bassam Moushmoush, MD have ACO affiliation data?

Bassam Moushmoush, MD is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563) and Vandalia Health Network (MSSP, ACO ID A4513).

What billing organization is linked to Bassam Moushmoush, MD?

Bassam Moushmoush, MD is linked to CARDIOVASCULAR CONSULTANTS PLLC (billing NPI 1588658199) in the available physician profile data.

Does Bassam Moushmoush, MD have Open Payments data?

Bassam Moushmoush, MD has 52 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.